$8.48
Price
$1.5B
Market Cap
—
P/E Ratio
21.7
Forward P/E
$-0.10
EPS (TTM)
—
Dividend Yield
$122M
Cash
$258M
Total Debt
182M
Shares Out
$5.25
$10.08
52-Week Range
Institutional Ownership of Xeris Biopharma Holdings Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Xeris Biopharma Holdings Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q1 | |||||
| SELL | EXIT | — | — | $3.66 | |
| 2024-Q4 | |||||
| SELL | -18.3% | 139.7K | $472142 | $3.23 | |
| 2024-Q2 | |||||
| BUY | +12.9% | 170.9K | $382899 | $2.01 | |
| 2021-Q4 | |||||
| BUY | NEW | 151.4K | $441000 | $2.10 | |
Insider Trading for Xeris Biopharma Holdings Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.